qXR-CTR vs Zio XT ECG Monitoring System
AI Verdict
Choose qXR-CTR if…
Choose qXR-CTR if your primary need is a rapid, AI-driven assessment of heart size and potential heart failure risk directly from standard chest X-ray images. This tool is ideal for initial screening or high-volume settings where quick, automated cardiothoracic ratio measurements can aid in risk stratification and guide further diagnostic steps.
View qXR-CTR →Choose Zio XT ECG Monitoring System if…
Choose the Zio XT ECG Monitoring System if you require continuous, long-term cardiac rhythm monitoring to detect and diagnose intermittent arrhythmias that may not be captured during a brief office visit. This wearable solution is best suited for patients experiencing infrequent symptoms or those needing extended monitoring for suspected or known rhythm disorders, offering high patient compliance and detailed data for comprehensive analysis.
View Zio XT ECG Monitoring System →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | qXR-CTR | Zio XT ECG Monitoring System |
|---|---|---|
| Pricing | Unknown | Contact for pricing |
| Deployment | Can be deployed on cloud or on-premise. The Qure.ai app receives DICOM studies via DICOM network protocol from medical systems (PACS/Modality) or can import DICOM from the local system. The received DICOM study is processed in Qure's cloud server, and AI-processed reports are displayed on the app. | Cloud-based (AWS EC2 platform), no on-premise hardware required. |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Yes AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Zio XT ECG Monitoring SystemTool B, the Zio XT ECG Monitoring System, offers superior patient usability with its wearable, wire-free, and water-resistant biosensor designed for up to 14 days of continuous wear, promoting high patient compliance and comfort. While Tool A automates a measurement, Tool B's focus on a seamless patient experience for long-term monitoring gives it an edge in overall usability.
Clinical Value
Zio XT ECG Monitoring SystemTool B provides continuous cardiac monitoring for up to 14 days, utilizing FDA-cleared AI and expert review for accurate arrhythmia detection and diagnosis, offering a comprehensive view of cardiac activity. Tool A focuses on automating a single measurement (CTR) from X-rays, which, while valuable, is more specific compared to Tool B's broader diagnostic capabilities for various arrhythmias.
Pricing & Value
Zio XT ECG Monitoring SystemTool B demonstrates greater transparency in its pricing, providing specific cost details for the UK (u00a3310 per patient) and proposed Medicare rates for the US ($229-$260.35). In contrast, Tool A's pricing is not publicly disclosed, requiring direct contact for information. This transparency allows for a clearer understanding of the investment required for Tool B.
Enterprise Readiness
qXR-CTRBoth tools demonstrate strong enterprise readiness with HIPAA compliance, BAA agreements, and FDA clearance. However, Tool A offers more flexible deployment options (Cloud, on-premise, hybrid), which can be crucial for large enterprises with diverse IT infrastructure requirements and data residency preferences. Tool B is exclusively cloud-based.
Innovation
Zio XT ECG Monitoring SystemTool B showcases greater innovation by combining a long-duration wearable ECG biosensor with FDA-cleared deep-learned AI and expert review for continuous, comprehensive arrhythmia detection. This integrated approach to remote patient monitoring pushes the boundaries of cardiac diagnostics. Tool A's automation of CTR measurement, while useful, is a more focused application of AI to an existing diagnostic method.
Support & Docs
Zio XT ECG Monitoring SystemWhile both companies likely offer support, iRhythm (Tool B) provides more readily accessible information on its website regarding professional and patient resources, including guides and dedicated support contact. Qure.ai (Tool A) mentions general 24/7 support and customer success teams for its solutions, but specific documentation or support channels for qXR-CTR are less transparently detailed online.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | qXR-CTR | Zio XT ECG Monitoring System |
|---|---|---|
| Name | qXR-CTR | Zio XT ECG Monitoring System |
| Company | Qure.ai Technologies | iRhythm Technologies |
| Primary Function | AI-powered software for automated cardiothoracic ratio (CTR) measurement from chest X-ray images, aiding in heart size assessment and potential heart failure risk. | Wearable, single-lead ECG biosensor for up to 14 days of continuous cardiac monitoring, utilizing FDA-cleared AI and expert review for arrhythmia detection and diagnosis. |
| Categories | Cardiology AI, Radiology & Imaging AI | Cardiology AI, Wearables & Remote Monitoring (RPM) |
| Specialties | Cardiology, Radiology | Cardiology, Emergency Medicine, Internal Medicine |
Videos
Demos, reviews, and walkthroughs featuring qXR-CTR and Zio XT ECG Monitoring System.
Frequently Asked Questions
More Comparisons
More matchups featuring qXR-CTR or Zio XT ECG Monitoring System
Backers
Who funded each tool's parent company.